Eurofins panlabs discovery services taiwan, LTD.:1293378 [19-001658] - testing of compounds for off-target activity in a broad panel of safety-related targets. Point of contact JON musselman.
Ended Purchase Order Awarded Last action
- Contract number
- 75N95019P00274
- Awardee
-
Eurofins Panlabs Discovery Services Taiwan, LTD. UEI N8VQW3HFJ385
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $80,750
Award facts
- Opportunity
-
- Testing of Compounds for Off-Target Activity in a Broad Panel of Safety-Related Targets Pre-Solicitation · 75N95019Q00111 · Posted Mar 21, 2019
- Testing of Compounds for Off-Target Activity in a Broad Panel of Safety-Related Targets Solicitation · Posted Apr 15, 2019
- Contract value 100% obligated
- $80,750.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Taiwan
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $80,750 |
About this award
This is a $80,750 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Panlabs Discovery Services Taiwan, LTD. The contract is for testing five small molecule compounds against a panel of 174 safety-related biological targets in order to predict potential safety issues as the compounds are advanced into clinical trials. The purpose is to support NCATS' work on developing new treatments for diseases such as myelodysplastic syndromes and acute myeloid leukemia. No set-aside was used for this contract.
Quick answers
Who was awarded contract 75N95019P00274?
75N95019P00274 was awarded to Eurofins Panlabs Discovery Services Taiwan, LTD. by National Institute on Drug Abuse (National Institutes of Health) on June 1, 2019.
How much is contract 75N95019P00274 worth?
The government has obligated $80,750 on 75N95019P00274.
Which agency awarded contract 75N95019P00274?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019P00274, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95019P00274 competed?
The extent of competition for 75N95019P00274 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award